A client with infective endocarditis is being started on intravenous antibiotics. What should the nurse include when teaching about this medication?

The treatment of infective endocarditis requires prolonged parenteral administration of bactericidal antibiotics to ensure the total eradication of organisms embedded within avascular vegetations. Because these vegetations protect bacteria from host defenses and antibiotic penetration, extended therapy is necessary to prevent relapse and ensure complete clinical resolution. A. Antibiotics for infective endocarditis are not administered for life. Therapy is intensive and long-term but has a definitive endpoint based on the clearance of blood cultures and clinical stabilization. Lifelong antibiotics are reserved for very specific, rare scenarios of recurrent prosthetic valve infections where surgery is not an option. B. Antibiotics are not changed every few days. The treatment regimen is determined by specific blood culture sensitivities. Once the effective antibiotic is identified, the patient remains on that specific medication for the entire duration of the course to maintain consistent therapeutic blood levels and effectively kill the specific invading pathogen. C. A 7 to 10-day course is far too short for the treatment of endocarditis. Such a brief duration would only suppress the bacteria without eradicating the deep-seated infection within the heart valves. Short courses are appropriate for simple infections like cystitis, but never for systemic endocardial infections which are highly resilient. D. The standard treatment duration for infective endocarditis is typically 2 to 6 weeks of intravenous therapy. Because the patient is usually hemodynamically stable after the first week but requires continued IV access, this treatment is frequently completed in a subacute rehab facility or at home via an outpatient parenteral antibiotic therapy (OPAT) program.